Showing results 53 to 71 of 71
< previous
| Issue Date | Title | Author(s) |
| 2019-12-01 | Quality use of medicines: Oral corticosteroids in advanced cancer | Pinkerton, E; Good, P; Kindl, K; Richard, R; Fischer, A; Hardy, JR |
| 2016 | Quantitative determination of the enantiomers of methadone in human plasma and saliva by chiral column chromatography coupled with mass spectrometric detection. | George, R; Lobb, M; Haywood, A; Khan, S; Hardy, J; Good, P; Hennig, S; Norris, R |
| 2017-01 | Rates and Predictors of Professional Interpreting Provision for Patients With Limited English Proficiency in the Emergency Department and Inpatient Ward. | Ryan, J; Abbato, S; Greer, R; Vayne-Bossert, P; Good, P |
| 2020 | Regular dosing compared with as-needed dosing of opioids for management of chronic cancer pain: systematic review and meta-analysis. | Edler-Buggy, S; Birtwistle, J; ElMokhallalati, Y; Kindl, K; Good, P; Bennett, MI |
| 2022-06-14 | Research agenda for medical cannabis in palliative care. | Gurgenci, T; Hardy, J; Good, P |
| 2012-11-01 | Specialists' experiences and perspectives on the timing of referral to palliative care: A qualitative study | Broom, A; Kirby, E; Good, P; Wootton, J; Adams, J |
| 2022-01-01 | Survival following palliative percutaneous nephrostomy tube insertion in patients with malignant ureteric obstruction: Validating a prognostic model | Gunawan, B; Foster, K; Hardy, J; Good, P |
| 2019-02-20 | Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults | Haywood, A; Duc, J; Good, P; Khan, S; Rickett, K; Vayne-Bossert, P; Hardy, JR |
| 2024-02-10 | The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life. | Haupt, LM; Haywood, A; Sutherland, HG; Yu, C; Albury, CL; Pharasi, A; Zunk, M; George, R; Griffiths, LR; Good, P; Hardy, J |
| 2017-04 | The Liminal and the Parallax: Living and Dying at the End of Life. | MacArtney, JI; Broom, A; Kirby, E; Good, P; Wootton, J |
| 2018-08 | The meaning and experience of bereavement support: A qualitative interview study of bereaved family caregivers. | Kirby, E; Kenny, K; Broom, A; MacArtney, J; Good, P |
| 2018-01-01 | The other side of “getting by”: A case study of interpreting provision decision-making and consequences for patients | Abbato, S; Ryan, J; Skelly, C; Good, P |
| 2024-08-21 | Top Ten Tips Palliative Care Clinicians Should Know About Designing a Clinical Trial in Palliative Care. | Gurgenci, T; O'Leary, C; Philip, J; Bruera, E; Davis, M; Agar, MR; Hui, D; Zimmermann, C; Yennu, S; Hardy, J; Mercadante, S; Rosa, WE; Good, P |
| 2024-07-24 | Top Ten Tips Palliative Care Clinicians Should Know About Interpreting a Clinical Trial. | Gurgenci, T; O'Leary, C; Hui, D; Yennu, S; Bruera, E; Davis, M; Agar, MR; Zimmermann, C; Philip, J; Mercadante, S; Hardy, J; Rosa, WE; Good, P |
| 2014-02-01 | The troubles of telling: Managing communication about the end of life | Broom, A; Kirby, E; Good, P; Wootton, J; Adams, J |
| 2023-01-01 | Understanding priorities of care: An assessment of FAMCARE-2 satisfaction surveys and thematic analysis in community palliative care | Cooper, M; Fischer, A; Dubrowin, N; Kilkenny, C; Good, P |
| 2022-09-05 | Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer. | Olson, RE; Smith, A; Huggett, G; Good, P; Dudley, M; Hardy, J |
| 2023-02 | 'What price do you put on your health?': Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer. | Olson, RE; Smith, A; Good, P; Dudley, M; Gurgenci, T; Hardy, J |
| 2019-02-01 | Why is optimisation of antimicrobial use difficult at the end of life? | Broom, J; Broom, A; Good, P; Lwin, Z |
